Sentences with phrase «as generic drugs»

The worry is revenue from Humira will drop off a cliff as generic drugs enter the market.

The worry is revenue from Humira will drop off a cliff as generic drugs enter the market.

Stada's owners are also mulling bids for the generic drug business being sold by Sanofi, the sources said, and might favor this combination over Merck as generic drugs are typically valued at a cheaper multiple.

But Slavitt's letter noted that EpiPen, since the fourth quarter of 1997, has been incorrectly reported by its sellers as a generic drug for the rebate program.

Generally understood as a provision permitting companies to test or experiment with patented inventions prior to an FDA submission - such as a generic drug maker prior to submission of an ANDA - the provision's scope has expanded over the years.

Nexium and Prevacid (which is also available as a generic drug, lansoprazole) are the two most popular proton pump inhibitors, according to the most recent government data.

Lithium is prescribed in the U.S. as a generic drug (Lithium Citrate or Lithium Carbonate) or under the brand names Lithobid, Eskalith and Lithate.

Not exact matches

The plan comes with other consumer - friendly perks, such as free email access to board - certified doctors 24 - 7, free generic prescription drugs, and three free physician visits per year.

The Food and Drug Administration (FDA) under Commissioner Scott Gottlieb is continuing its quest to ramp up generic drug approvals, this time for complex generics that could compete with products such as Mylan's EpiDrug Administration (FDA) under Commissioner Scott Gottlieb is continuing its quest to ramp up generic drug approvals, this time for complex generics that could compete with products such as Mylan's Epidrug approvals, this time for complex generics that could compete with products such as Mylan's EpiPen.

However analysts point to a bounce in Teva's shares over the past four months and a slowing in the rate of decline of U.S. generic drug prices as bright spots.

The plan also calls for generic versions of any drug or treatment to be available as soon as the Food and Drug Administration approvesdrug or treatment to be available as soon as the Food and Drug Administration approvesDrug Administration approves it.

Merritt cited a backlog among approval for generic drugs at the FDA as one of the reasons that many drugs don't face generic competition just yet.

But it was not made clear whether Amazon will enter as a drug wholesaler, meaning business - to - business, or sell generic medications as a retailer.

Generic drug giant Mylan is cutting its financial outlook as it continues to face pressure from falling generic drug prices (a fate that similarly struck rival Teva PharmaceutGeneric drug giant Mylan is cutting its financial outlook as it continues to face pressure from falling generic drug prices (a fate that similarly struck rival Teva Pharmaceutgeneric drug prices (a fate that similarly struck rival Teva Pharmaceuticals).

Revenue growth has slowed as many companies sink more resources into developing the next blockbuster drug; what's more, the «patent cliff» for the last round of megabillion - dollar drugs — when generics firms typically see a sales spurt — happened a few years ago.

Given its areas of specialization, Gilead wouldn't benefit as much from consolidation as, say, a generic - drug company would, but it still faces pricing pressure: To appease Medicaid and other insurers, Gilead is already steeply discounting its hep - C drugs, which can cost more than $ 80,000 for a 12 - week course.

One major reason is that biosimilars aren't the same as generics of chemical drugs.

Clinton didn't name the drug in her ad, but Valeant was quick to identify it as the injectable migraine treatment D.H.E. 45 — which went generic in 2003, before Valeant even owned it.

• Mallinckrodt (NYSE: MNK) is exploring a sale of its generic drug unit in a deal that could fetch as much as $ 2 billion, according to Reuters.

Jean Coutu has a network of 417 franchised stores in Quebec, New Brunswick and Ontario under several banners including PJC Jean Coutu as well as a subsidiary that makes generic drugs.

That's an even rarer feat for a generic drug maker such as Mylan, which makes most of its revenue not on brand - name drugs, but on cheaper, equivalent versions of other companies» branded medications.

But it won't be nearly enough to make up for the money lost as generic - drug prices are capped, she says.

And despite «swimming upstream» against the generic - drug changes, as Canaccord Genuity analyst Derek Dley put it in an interview, Shoppers doesn't plan on giving in just yet.

Generic versions will also continue to be introduced as Amgen's drug patents expire over time.

Acquiring Akorn would add around $ 1 billion in annual sales to Fresenius» drugmaking division, giving it a significantly larger presence in eyecare and other areas widely perceived as somewhat insulated from generic drug pricing pressure.

Bain and Cinven, who earlier this year took control of Germany's Stada, are hoping to use the Merck unit as a buy - and - build platform for Stada, which makes generic drugs and consumer care products and had annual revenues of more than 2 billion euros in 2016, the sources said.

Generic drugs are poised to steal market share as patent protections on a number of branded drugs expire.

As long as that strategy continues to control the decline in Remicade's sales, then growth from these drugs should offset any drop — at least until J&J has to deal with a generic ZytigAs long as that strategy continues to control the decline in Remicade's sales, then growth from these drugs should offset any drop — at least until J&J has to deal with a generic Zytigas that strategy continues to control the decline in Remicade's sales, then growth from these drugs should offset any drop — at least until J&J has to deal with a generic Zytiga.

The U.S. Food and Drug Administration's approval of Mylan N.V. (NASDAQ: MYL)'s generic version of Copaxone for the treatment of relapsing multiple sclerosis should be seen as a «clear negative» for Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA)'s Glatopa franchise, analysts at Baird said.

(Reuters)- Mallinckrodt Plc (MNK.N) is exploring a sale of its generic drug unit, in a deal that could fetch as much as $ 2 billion and help pivot the specialty pharmaceutical maker toward higher - margin branded drugs, according to people familiar with the matter.

When a generic drug is not bioequivalent to the name - brand version, it might still be approved for another use, but not be approved as a substitute for the name - brand version.

The lawsuit takes primary aim against pharmaceutical companies that make promote, market and distribute opioid - based drugs such as OxyContin and Percocet and generics such as oxycodone and hydrocodone.

The chairman of its GP committee's clinical and prescribing sub-committee, Bill Beeby, said: «The PAC report acknowledges that there has been a substantial increase in prescribing generic drugs in recent years and with just over two per cent of the overall drugs bill identified as potential savings it shows that the official advice is already being heeded.»

As prescription drug prices — both brand - name and generic — continue to rise, a number of bipartisan proposals to combat the issue have been put on the table.

But Gilead's latest agreement with the Medicines Patent Pool aims to have new drugs ready for generic manufacturers as soon as they are available in high - income countries.

The drugs are now available as lower - priced generics, poised to further drive consumption.

The rationale for using spironolactone - an inexpensive, generic, medication - stems from the pioneering research of Bertram Pitt, MD, University of Michigan School of Medicine, who showed the benefit of this class of drugs in patients with heart failure and reduced ejection fraction, and who also served as chair of the TOPCAT Steering Committee.

Increasingly, international donors are withdrawing support from these countries, and drug makers such as Gilead are likely to see them as untapped markets for their products and thus exclude them from generic licensing deals.

Although most of the shortages affect old, generic drugs, clinical trials often use these staples, either as controls or in combination with experimental medicines, including the genetically targeted drugs that many hope will revolutionize cancer care.

FDA officials defended the agency's handling of the Cetero case as prudent and scientifically sound, noting that the agency has found no discrepancies between any original drug and its generic copy and no sign that any patients have been harmed.

Bioequivalence studies measure whether a generic drug acts the same in the body as the name - brand drug; bioavailability studies measure how much drug gets into a patient's system.

For example, one of these generic drugs was ibuprofen, sold as gelatin capsules by one of the nation's largest grocery - store chains for months before the FDA received assurance they were safe.

The vast majority, 81, were generic versions of brand - name drugs on which Cetero scientists had often run critical tests to determine whether the copies did, in fact, act the same in the body as the originals.

The decline was due to increased use of generic drugs as some popular brand - name drugs lost patent protection, increases in cost - sharing requirements, and lower spending on new medicines.

Every 6 hours, like clockwork, Seandradh and Al give their boys Cystagon (a trademarked drug with the generic name Cystagon), as well as oversee treatment of other related conditions.

But as its patent expires on November 30 and its first generic competitor takes the stage, Lipitor is also a painful reminder of the challenge that such «patent cliffs» pose for the big drug companies, including Lipitor's developer Pfizer, based in New York.

Similarly, prices of most other ADHD drugs would be higher — with an average increase of almost 4.6 % — with some, such as Dexedrine SR and its generic, increasing by as much as 8.69 % ($ 43.75 instead of $ 40.25) and 9.38 % ($ 38.42 instead of $ 35.14) respectively.

A generic drug contains the same active ingredient, which provides therapeutic benefit, as does the brand - name version.

But to be fair, much of the concern is rooted in some scary generic drug scandals, in which toxic substances made it into a medication that was produced overseas, such as occurred with heparin in 2008.

According to the FDA, the rules that it has set to regulate generic drugs are just as tough as for brand - name meds.